Steve Walsh joins Carticept Medical as Vice President of Research and Development

Life Science Partner recruits biomaterials expert to lead synthetic cartilage product development

Life Science Partner announces the recruitment of Steve Walsh, PhD, a senior biomaterials technology and development expert, to Carticept Medical to become Vice President, Research and Development for the company.   Carticept Medical is an Atlanta-based medical device company developing novel therapies designed to address the shortcomings of current conservative and surgical treatment options for patients with osteoarthritis or cartilage injuries.

In his previous role at Cyrolife, another Atlanta-based biotechnology company, Walsh was responsible for leading Biomaterials Technologies and Product Development for the company’s implantable biological devices, surgical adhesives and biomaterials for use in cardiac, vascular, general and reconstructive surgery.  Before his tenure at Cyrolife, Walsh served as Manager of the Implantable Device Development Engineering Group at BioControl Technology in Indiana, PA.   In his new role at Carticept, Walsh will have key responsibility for managing R&D efforts for the company’s synthetic cartilage products and the pipeline portfolio of novel therapeutic solutions.

“Walsh is a talented biomaterials scientist with a deep intellect and passion for his work,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “His deep knowledge base and broad development and process abilities will greatly benefit the important clinical and commercial efforts at Carticept.”

Walsh earned his Bachelor of Science in Plastics Engineering at the University of Lowell in Lowell Massachusetts and his Masters and Doctor of Philosophy degrees in Macromolecular Science at Case Western Reserve University in Cleveland, Ohio.